Canadian Perspective on Trilaciclib improving overall survival

Current European perspective in the optimal current regimens in the metastatic setting

DNA repair mutations beyond germline BRCA: Do they matter for patient management? Why treat differently?

HIGHLIGHTS from SABCS: Interview with Andrea Hutton, breast cancer survivor, patient advocate, author

HIGHLIGHTS from SABCS: ctDNA May Help Predict Recurrence in ETNBC: lack may signal improved outcomes